388 related articles for article (PubMed ID: 29221792)
41. Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT
Brys I; Halje P; Scheffer-Teixeira R; Varney M; Newman-Tancredi A; Petersson P
Exp Neurol; 2018 Apr; 302():155-168. PubMed ID: 29339052
[TBL] [Abstract][Full Text] [Related]
42. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine.
Castañé A; Kargieman L; Celada P; Bortolozzi A; Artigas F
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1353-61. PubMed ID: 25914158
[TBL] [Abstract][Full Text] [Related]
43. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
Kometer M; Schmidt A; Jäncke L; Vollenweider FX
J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
[TBL] [Abstract][Full Text] [Related]
44. 5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.
Abiero A; Botanas CJ; Sayson LV; Custodio RJ; de la Peña JB; Kim M; Lee HJ; Seo JW; Ryu IS; Chang CM; Yang JS; Lee YS; Jang CG; Kim HJ; Cheong JH
Behav Brain Res; 2019 Feb; 359():828-835. PubMed ID: 30053461
[TBL] [Abstract][Full Text] [Related]
45. Effects of Hallucinogens on Neuronal Activity.
Lladó-Pelfort L; Celada P; Riga MS; Troyano-Rodríguez E; Santana N; Artigas F
Curr Top Behav Neurosci; 2018; 36():75-105. PubMed ID: 28238186
[TBL] [Abstract][Full Text] [Related]
46. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
47. Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain.
Rueter LE; Blier P
Br J Pharmacol; 1999 Feb; 126(3):627-38. PubMed ID: 10188973
[TBL] [Abstract][Full Text] [Related]
48. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
Gronier B
Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
[TBL] [Abstract][Full Text] [Related]
49. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
50. Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
Fantegrossi WE; Reissig CJ; Katz EB; Yarosh HL; Rice KC; Winter JC
Pharmacol Biochem Behav; 2008 Jan; 88(3):358-65. PubMed ID: 17905422
[TBL] [Abstract][Full Text] [Related]
51. 5-HT(1A) receptors direct the orientation of plasticity in layer 5 pyramidal neurons of the mouse prefrontal cortex.
Meunier CN; Amar M; Lanfumey L; Hamon M; Fossier P
Neuropharmacology; 2013 Aug; 71():37-45. PubMed ID: 23523560
[TBL] [Abstract][Full Text] [Related]
52. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
[TBL] [Abstract][Full Text] [Related]
53. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex.
Yuen EY; Jiang Q; Chen P; Feng J; Yan Z
J Biol Chem; 2008 Jun; 283(25):17194-204. PubMed ID: 18442977
[TBL] [Abstract][Full Text] [Related]
54. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
55. PKCδ Knockout Mice Are Protected from Dextromethorphan-Induced Serotonergic Behaviors in Mice: Involvements of Downregulation of 5-HT
Tran HQ; Lee Y; Shin EJ; Jang CG; Jeong JH; Mouri A; Saito K; Nabeshima T; Kim HC
Mol Neurobiol; 2018 Oct; 55(10):7802-7821. PubMed ID: 29468562
[TBL] [Abstract][Full Text] [Related]
56. Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation.
Chang CW; Poteet E; Schetz JA; Gümüş ZH; Weinstein H
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):213-25. PubMed ID: 18762202
[TBL] [Abstract][Full Text] [Related]
57. Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT
Werle I; Nascimento LMM; Dos Santos ALA; Soares LA; Dos Santos RG; Hallak JEC; Bertoglio LJ
Br J Pharmacol; 2024 Jun; 181(11):1671-1689. PubMed ID: 38320596
[TBL] [Abstract][Full Text] [Related]
58. The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
Reckweg JT; Uthaug MV; Szabo A; Davis AK; Lancelotta R; Mason NL; Ramaekers JG
J Neurochem; 2022 Jul; 162(1):128-146. PubMed ID: 35149998
[TBL] [Abstract][Full Text] [Related]
59. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors.
Smith BN; Sollars PJ; Dudek FE; Pickard GE
J Biol Rhythms; 2001 Feb; 16(1):25-38. PubMed ID: 11220775
[TBL] [Abstract][Full Text] [Related]
60. Modulatory Role of Postsynaptic 5-Hydroxytryptamine Type 1A Receptors in (±)-8-Hydroxy-N,N-dipropyl-2-aminotetralin-Induced Hyperphagia in Mice.
Brosda J; Müller N; Bert B; Fink H
ACS Chem Neurosci; 2015 Jul; 6(7):1176-85. PubMed ID: 25781502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
